1
2
3
4
5
6
7
8
9
10
11

Mirum Pharmaceuticals is dedicated to creating life-changing therapies for patients with liver diseases.

12
13
14
15
Extra 1

Our medicines are designed to address the severe itching and progressive liver damage of cholestatic liver diseases for children like Trey.

16
17
18

We don’t just work on behalf of patients, we work with them. We are currently recruiting patients for clinical trials.

Latest News

  • Mirum Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021

    July 29, 2021

  • Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea

    July 26, 2021

  • Mirum Pharmaceuticals Presents Analyses From Its Rare Liver Disease Programs at the EASL International Liver Congress 2021

    June 23, 2021

  • Mirum Pharmaceuticals to Showcase Analyses From Its Rare Liver Disease Programs at The International Liver Congress 2021

    June 16, 2021

  • Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    June 10, 2021